| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
6,140 |
5,957 |
$1.03M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
5,259 |
5,138 |
$703K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
5,555 |
5,454 |
$599K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
642 |
626 |
$87K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
3,851 |
3,705 |
$79K |
| 80053 |
Comprehensive metabolic panel |
6,492 |
6,159 |
$51K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
706 |
705 |
$50K |
| G0378 |
Hospital observation service, per hour |
60 |
53 |
$45K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
467 |
460 |
$37K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
8,726 |
8,220 |
$35K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
2,125 |
2,042 |
$32K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
2,695 |
2,591 |
$19K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
109 |
108 |
$18K |
| 70450 |
Computed tomography, head or brain; without contrast material |
332 |
321 |
$15K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
193 |
189 |
$14K |
| 71045 |
Radiologic examination, chest; single view |
1,891 |
1,824 |
$11K |
| 84484 |
|
1,621 |
1,485 |
$11K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
853 |
814 |
$10K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
137 |
129 |
$9K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
138 |
131 |
$8K |
| 84443 |
Thyroid stimulating hormone (TSH) |
284 |
278 |
$7K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
287 |
270 |
$7K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
990 |
927 |
$7K |
| 80061 |
Lipid panel |
384 |
376 |
$6K |
| 83690 |
|
1,716 |
1,633 |
$6K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
531 |
498 |
$5K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
58 |
58 |
$5K |
| 80050 |
General health panel |
111 |
108 |
$5K |
| 0002A |
|
117 |
115 |
$5K |
| 81001 |
|
2,341 |
2,263 |
$5K |
| 81025 |
|
1,347 |
1,314 |
$4K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
46 |
45 |
$4K |
| 0001A |
|
110 |
109 |
$4K |
| 83605 |
|
563 |
500 |
$3K |
| 71046 |
Radiologic examination, chest; 2 views |
222 |
220 |
$3K |
| 83880 |
|
117 |
109 |
$3K |
| 83735 |
|
470 |
427 |
$2K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
247 |
242 |
$2K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
118 |
98 |
$2K |
| 85379 |
|
249 |
246 |
$2K |
| 36415 |
Collection of venous blood by venipuncture |
1,432 |
1,270 |
$2K |
| 70498 |
|
12 |
12 |
$2K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
70 |
68 |
$2K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
239 |
232 |
$1K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
75 |
67 |
$1K |
| 85610 |
|
362 |
321 |
$1K |
| 85730 |
|
217 |
211 |
$1K |
| 86803 |
|
69 |
67 |
$962.98 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
18 |
18 |
$930.43 |
| 81003 |
|
406 |
391 |
$908.49 |
| 72125 |
Computed tomography, cervical spine; without contrast material |
12 |
12 |
$895.40 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
3,312 |
2,658 |
$838.78 |
| 96376 |
|
58 |
57 |
$791.28 |
| 84466 |
|
27 |
27 |
$563.71 |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
35 |
33 |
$539.78 |
| 80076 |
|
58 |
57 |
$535.00 |
| 80305 |
|
57 |
54 |
$535.00 |
| 87040 |
|
30 |
28 |
$521.92 |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
14 |
14 |
$511.32 |
| 84439 |
|
56 |
56 |
$477.64 |
| 84702 |
|
28 |
24 |
$437.11 |
| 82728 |
|
28 |
28 |
$421.00 |
| 82607 |
|
32 |
31 |
$418.36 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
18 |
16 |
$354.91 |
| 73630 |
|
44 |
42 |
$346.18 |
| 87081 |
|
77 |
71 |
$318.55 |
| 73130 |
|
40 |
37 |
$309.60 |
| 82550 |
|
49 |
47 |
$307.12 |
| 83540 |
|
28 |
28 |
$280.02 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
55 |
50 |
$240.80 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,931 |
1,360 |
$193.50 |
| 82570 |
|
27 |
25 |
$168.22 |
| 73560 |
|
14 |
14 |
$145.52 |
| 84145 |
|
12 |
12 |
$133.27 |
| 85027 |
|
14 |
14 |
$124.34 |
| 84703 |
|
12 |
12 |
$111.18 |
| 85652 |
|
40 |
39 |
$97.50 |
| 82043 |
|
12 |
12 |
$95.96 |
| 87186 |
|
18 |
17 |
$93.92 |
| 84999 |
|
27 |
26 |
$66.56 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,223 |
997 |
$56.78 |
| 82962 |
|
58 |
43 |
$41.09 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
116 |
82 |
$33.10 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
289 |
251 |
$31.36 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
108 |
96 |
$2.49 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
884 |
790 |
$0.01 |
| A9270 |
Non-covered item or service |
5,068 |
3,019 |
$0.00 |
| J3490 |
Unclassified drugs |
164 |
121 |
$0.00 |
| J2704 |
Injection, propofol, 10 mg |
50 |
44 |
$0.00 |